Radiation Retinopathy After Head and Neck Cancer Treatment: What Survivors Should Watch For
Radiation Retinopathy at a Glance
Call your eye doctor the same day if your sight changes suddenly, even years after your cancer treatment ended. Most changes can be treated when they are caught early.
- A sudden drop in vision, or new blurring in one eye
- A sudden shower of new floaters, or flashing lights
- A curtain or dark shadow across part of your sight
- Severe eye pain with redness, or halos around lights
These signs can come from bleeding inside the eye or from high pressure in the eye. Both are late problems of radiation damage to the retina, and both are treatable. Radiation retinopathy is reported in about 6 of every 100 people treated with radiation for brain, head and neck tumors, usually about 3 years after treatment, and the researchers who pooled those studies note that eyes were often only checked once someone complained, so the real rate is likely higher.1 Slower changes matter too. Book an eye exam within a few weeks for blurring that creeps up over months.
It is damage to the tiny blood vessels in the retina, the light-sensing layer at the back of your eye, caused by radiation that passed through or near the eye during cancer treatment. The damaged vessels leak and close off, so the retina swells in places and loses its blood supply in others; the earliest visible signs are microaneurysms, small bulges in the vessel walls.2 It is not a return of the cancer, and it is not something you did.
The retina sits close to the sinuses, the nasopharynx and the base of the skull. A beam shaped to cover a tumor in those places can clip the back of the eye even when the eye is not the target. The pooled studies that reported retinopathy covered sinonasal tumors, nasopharyngeal tumors, maxillary sinus carcinoma, optic nerve sheath meningioma, other head and neck cancers, skull base meningioma and olfactory tumors, and none of them reported retinopathy when the prescribed tumor dose stayed under 50 Gy.1 That reflects what those studies happened to report rather than a proven safe dose. Ask your radiation oncologist which technique was used in your case and how much dose the eye received.
This is the part that catches survivors off guard: the gap is measured in years, not weeks. Across pooled studies, the median time from radiotherapy to diagnosis was 39 months, with individual cases ranging from 8 months to more than 9 years.1 Reports stretch even further, including a patient diagnosed 17 years after radiotherapy for nasopharyngeal carcinoma.3 So a new vision change long after you were discharged from cancer follow-up is still worth linking back to that treatment when you see an eye doctor.
What Radiation Does to the Blood Vessels in Your Retina
Radiation injures the cells lining the smallest retinal vessels. Some vessels become leaky, letting fluid into the retina. Others close entirely, starving patches of retina of oxygen. The changes an eye doctor can see include microaneurysms, swelling of the retina and macula, cotton-wool spots (pale patches where nerve fibers have lost their blood supply), hard exudates (fatty deposits) and widened vessels; where vessels have closed off, the ischemic changes include patches of retina with no capillary flow, new vessel growth, bleeding into the jelly of the eye and retinal detachment.2 The oxygen-starved retina then releases signals that drive fragile new vessels, which is the stage that threatens sight most.
Nobody can tell you in advance whether your eyes will be affected. Several factors are known to shift the odds, and your radiation oncologist can tell you which apply to your treatment plan.
- A higher radiation dose reaching the retina
- A tumor sitting close to the eye or the optic nerve
- Diabetes, which damages the same vessels by another route
- Chemotherapy given alongside radiation
Diabetes substantially increases the risk of vision loss in people who develop radiation retinopathy, and external beam series have reported retinopathy in about 53 of every 100 eyes that received 45 to 55 Gy to half or more of the retina.2 Ask for your dose figures. They belong in your eye record.
Radiation to this part of the head can affect several eye structures, and they behave differently. Knowing which one is causing your symptoms decides the treatment.
- Retinopathy: leaking and blocked vessels at the back of the eye
- Optic neuropathy: damage to the nerve carrying vision to the brain
- Cataract: clouding of the lens, usually correctable with surgery
- Dry eye: from damage to the tear glands and eyelids
In the pooled review, optic neuropathy was reported in about 2 of every 100 patients irradiated for brain, head and neck tumors, and it was more common above a 50 Gy prescribed dose than below it.1 Retinopathy and optic neuropathy can occur together in the same eye.
Symptoms and How the Damage Shows Up
Most people notice a gradual change in central vision rather than a sudden loss. Reading gets harder before anything else does, because the macula sits in the part of the retina that swells first.
- Blurred or distorted central vision, so straight lines look bent
- Trouble reading small print or recognizing faces
- A dim or washed-out patch in the middle of your view
- Floaters, if a fragile vessel has bled a little
Cover one eye at a time when you test yourself. A good eye compensates so well that months of change in the other one can pass unnoticed.
Retinal vessels can be injured long before you feel anything, which is the main argument for scheduled eye checks rather than symptom-triggered ones. Macular swelling is one of the earliest changes radiation retinopathy causes. It has been seen in as many as 33 of every 100 eyes that showed no signs of retinopathy on examination, and a scan can pick it up almost 5 months before an exam can.2 OCT angiography shows changes in the retinal circulation before any clinical sign or symptom appears.4
When enough retina has lost its blood supply, fragile new vessels grow. They bleed into the eye, and they can block the eye's drainage channels, raising pressure painfully. This is the proliferative stage, and it is the reason for the same-day warning signs at the top of this page.
In eyes treated with plaque brachytherapy for tumors inside the eye, the proliferative stage develops in about 3 to 25 of every 100 eyes, and about 1 to 12 of every 100 treated eyes were eventually removed because of the high-pressure glaucoma that can follow.5 Those figures come from eye-tumor treatment, where retinal doses are far higher, so read them as a picture of what the late stage can do rather than as your own odds. That outcome is exactly what monitoring and early treatment aim to head off.
How Radiation Retinopathy Is Diagnosed
Diagnosis rests on an eye doctor examining the retina with your pupils widened by drops, then matching what they see against your radiation history. Bring the name of your cancer, the year you were treated, and your radiation dose if you have it.
The examination takes a couple of hours with dilation, and you should arrange not to drive yourself home. Your doctor is looking for microaneurysms, small hemorrhages, cotton-wool spots and swelling at the macula, and checking whether the optic nerve looks affected as well.
Optical coherence tomography takes a cross-section image of the retina in seconds, without touching your eye. It measures macular swelling precisely, so your team can compare visit to visit rather than relying on impressions.
OCT angiography maps the retinal circulation without an injection, showing where capillaries have dropped out and whether the vessel-free zone at the center of the macula has widened. Both scans can show radiation damage before an examination alone would, which is what makes early treatment possible.24 Ask to see your scans; the pictures make the plan easier to follow.
Fluorescein angiography uses a dye injected into an arm vein and a rapid series of retinal photographs. It maps leakage and, more importantly, the areas where blood is no longer reaching the retina.
Areas of capillary non-perfusion are among the most consistent findings in radiation retinopathy, and cases have shown an enlarged foveal avascular zone with telangiectatic vessels around the fovea.6 Visual field testing is added when the optic nerve may also be involved, since nerve damage takes side vision rather than central detail.
Treatment Options and What They Can Achieve
Anti-VEGF medicines, given as an injection into the eye after numbing drops, are the main treatment for the macular swelling that blurs central vision. They are used off-label for radiation damage, meaning this particular use is not on the drug's label and rests on published clinical experience rather than a licensed indication.
Starting these injections earlier is linked to better vision: in a 10-year series of 120 patients about 80 of every 100 stayed within two lines of their starting vision, and in a case-matched comparison of 14 treated patients against 14 untreated ones, mean final acuity was 20/32 with treatment and 20/160 without.4 Those are small, non-randomized comparisons, so treat them as encouraging rather than settled.
Steroids and laser are the other established tools, each with a particular job and a particular cost.
| Treatment | What it is used for | What to weigh |
|---|---|---|
| Anti-VEGF injections | Macular swelling, new vessels | Repeated visits, often for years |
| Steroid injection or implant | Swelling that persists | Raises cataract and pressure risk |
| Laser to the outer retina | New vessels, bleeding risk | Can affect side vision |
In brachytherapy-treated eyes, a single intravitreal triamcinolone injection improved or stabilized vision in about 91 of every 100 eyes at 1 month but only about 45 of every 100 by 6 months, and panretinal laser produced regression of new vessels in about 66 of every 100 eyes.5 Steroid benefit fading by six months is why repeat treatment is usually part of the plan.
Surgery is reserved for the late stage. A vitrectomy removes blood that will not clear from inside the eye, releases scar tissue pulling on the retina, and lets the surgeon apply laser directly.
It is a bigger undertaking than an injection, and it addresses the consequences of vessel closure rather than the closure itself. Ask your surgeon what specific problem the operation is meant to fix, what vision is realistic afterwards, and what will still need injections once you have healed.
Treatment aims to keep the vision you still have and to settle swelling that is blurring it. Retina already destroyed by loss of blood supply does not grow back, so the honest goal is preservation more than restoration.
Spontaneous improvement without treatment is very uncommon, and untreated proliferative disease tends to progress.2 That is the argument for acting early rather than watching. It is also why nobody can promise you a particular number of letters on a chart.
Complications, Vision Outlook and Staying Ahead of It
Several complications follow from the same vessel damage, and each has its own treatment. Knowing the list makes your appointments easier to follow.
- Macular swelling, the most common cause of blurred central vision
- Bleeding into the jelly of the eye from fragile new vessels
- High pressure inside the eye from new vessels blocking drainage
- Retinal detachment pulled by scar tissue
- Radiation damage to the optic nerve alongside the retina
Every item on that list has a treatment, and most respond better when caught early. That is the whole case for keeping scheduled appointments during years when nothing feels wrong.
Outcomes vary widely, mostly according to how much retina lost its blood supply and how early treatment started.
Follow-up about every 6 months is suggested for people with no signs of retinopathy, with the interval tailored once changes appear.2 Published vision figures come mainly from eye-tumor treatment, where radiation doses to the retina are far higher than in head and neck treatment, so they overstate what most survivors of sinus or nasopharyngeal cancer should expect. Your own outlook is a conversation with your retina specialist, not a number from a page.
This is the part of the problem you have direct influence over. Diabetes and high blood pressure damage the same small retinal vessels, so poor control adds injury on top of the radiation injury.
Bring your eye findings to whoever manages your diabetes or blood pressure, and tell them the retina is already vulnerable. Steady control will not undo radiation damage, and it does remove one compounding factor. Smoking cessation support is worth asking about for the same reason.
Eye Checks After Head and Neck Radiation
Not every head and neck cancer survivor needs retinal surveillance, and the deciding factor is how much radiation reached the eye rather than which cancer you had.
The systematic review authors recommend ophthalmologic evaluation for patients who received more than 60 Gy to the optic nerve or more than 50 Gy to parts of the retina, with baseline visual acuity, visual field testing, OCT and OCT angiography.1 Your radiation oncologist can pull those dose figures from your treatment plan. Ask for them in writing.
A general eye exam is a reasonable starting point, but interpreting radiation damage needs a retina specialist with your dose information in hand.
Ask your cancer team to make the referral rather than arranging it yourself, so your radiation records travel with you. If nothing is found, follow-up roughly twice a year is a common pattern in the first years after treatment. If swelling is found, visits become more frequent, because injection intervals are set by what your scans show.
Between scheduled visits, some changes should move you to the phone. Say clearly that you had radiation to the head or neck, because that history changes how quickly you are seen.
- Any sudden loss of vision, or a shadow that will not clear
- New floaters appearing in a rush rather than one at a time
- Eye pain with redness, or halos around lights
- Straight lines that have started to look bent
The first three point to bleeding or raised pressure, which need care within a day. The last points to macular swelling, which needs an appointment within a week or two rather than an emergency visit.
Common Questions About Radiation Retinopathy
No. Radiation retinopathy is late damage to blood vessels from the treatment itself, not a sign that the tumor has returned. Your oncology team will still want to know about it, because they may want imaging for their own reasons, and because your dose records help the eye team. Tell both teams about each other. The two sets of appointments work much better when the records travel between them.
Usually a few years, and sometimes far longer. Pooled studies put the median at a little over 3 years from treatment, with reported cases from about 8 months out to more than 9 years, and single reports stretching to 17 years. That long tail is the reason a new vision change in a survivor deserves an eye exam even decades later. Mention the radiation history at the appointment; it is easy for a new clinician to miss.
Often for a long time, though not always at the same frequency. Radiation damage does not resolve the way an infection does, so treatment tends to be maintenance rather than a course you finish. Many people move to longer intervals once scans are stable, and some need a return to shorter intervals later. Your intervals should be set by your OCT scans and vision, not by a fixed calendar.
Prevention mostly happens before and during your radiotherapy, through planning that spares the retina and optic nerve. After treatment, the practical steps are scheduled eye checks, keeping diabetes and blood pressure under control, and acting quickly on symptoms. Preventive injections have been studied in eye-tumor patients with mixed results, and they are not standard care for head and neck survivors.
Most people describe pressure rather than pain. Your eye is numbed with drops or gel first, and often with a small anesthetic injection under the surface, so the injection itself is brief. Afterwards you may see floaters from the medicine, feel gritty for a day, and have a red patch on the white of the eye. Ask for a step-by-step description beforehand if the idea worries you.
It depends on how the beam was shaped. A tumor to one side may deliver a high dose to one eye and very little to the other, while a midline nasopharyngeal tumor can reach both. Cases of damage in both eyes are well described. Your eye doctor examines both eyes at every visit regardless, since the eye with less exposure can still be affected later.
More Questions Survivors Ask
It could be, and radiation causes cataracts too. A cataract clouds vision slowly and painlessly, and it is corrected with surgery. Radiation retinopathy blurs the center of your vision and distorts straight lines. The two can occur together, which is why an examination and a scan settle the question rather than symptoms alone. If cataract surgery has already been done and vision is still blurred, the retina is the next place to look.
No supplement has been shown to treat radiation retinopathy, and none should replace injections or laser. Eye supplements studied for macular degeneration were tested in different patients with a different disease, so their results do not transfer here. Tell your clinicians what you take anyway, including over-the-counter products, because some interact with cancer medicines and blood thinners.
That depends on your measured vision and visual field, not on the diagnosis itself. Many people with early radiation retinopathy meet their local driving standard and continue driving. Ask your eye doctor to test you against that standard rather than guessing. If you are told to stop, ask about low vision services, because magnifiers, lighting advice and travel support exist and are underused.
Bring your radiation records if you can get them, especially the total dose and the dose to the eye or optic nerve. Add a list of your current medicines, your most recent diabetes and blood pressure results, and a note of when your vision changed and how. If you have old glasses prescriptions or previous eye reports, bring those too. This history often shortens the path to a diagnosis considerably.
- How much radiation reached my retina and optic nerve?
- Is the blurring from swelling in my macula, from the optic nerve, or from a cataract?
- What does my OCT scan show, and can you show me the change since last time?
- What is the goal of the treatment you are recommending: holding my vision steady, or improving it?
- How often will I need injections, and how will we decide to space them out?
- What changes should make me call you before my next appointment?
- Cancers (Basel) (2023). Radiation-Induced Retinopathy and Optic Neuropathy after Radiation Therapy for Brain, Head, and Neck Tumors: A Systematic Review (78 studies, 11,279 patients).
- Clinical Ophthalmology (2021). Radiation Retinopathy: Detection and Management Strategies (narrative review).
- Indian Journal of Ophthalmology (2022). Bilateral radiation retinopathy 17 years following radiotherapy for nasopharyngeal carcinoma: a diagnostic and therapeutic challenge during COVID-19 lockdown (case report).
- Eye (London) (2022). Early anti-VEGF treatment for radiation maculopathy and optic neuropathy: lessons learned (review).
- Journal of Contemporary Brachytherapy (2023). Radiation retinopathy following episcleral brachytherapy for intraocular tumors: current treatment options (narrative review).
- Pakistan Journal of Medical Sciences (2016). Delayed visual loss due to radiation retinopathy (case report).